Pfizer Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Asset Breakdown FY2016
Total Assets: $171.62B
Liabilities Breakdown FY2016
Total Liabilities: $111.78B
Asset Breakdown
Total Assets: $171.62B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $2.60B | 1.5% |
| Accounts Receivable | $8.23B | 4.8% |
| Inventory | $6.78B | 4.0% |
| Property, Plant & Equipment | $13.32B | 7.8% |
| Goodwill | $54.45B | 31.7% |
| Intangible Assets | $52.65B | 30.7% |
| Other Assets | $33.60B | 19.6% |
Liabilities Breakdown
Total Liabilities: $111.78B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $4.54B | 4.1% |
| Long-Term Debt | $31.40B | 28.1% |
| Other Liabilities | $75.84B | 67.9% |